NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Garywdward71, absolutely YES. In fact, if NWBio decided to pursue DCVax-L approval under the FDA Real Time Oncology Review (RTOR) program, then the FDA would require that NWBio submit the DCVax-L Phase III top line data (TLD) to the FDA first, to start the RTOR BLA approval process.

Take a look at this message post:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=161467585